PL396723A1 - Zastosowanie czynników wiążących receptory EDG w chorobach nowotworowych - Google Patents

Zastosowanie czynników wiążących receptory EDG w chorobach nowotworowych

Info

Publication number
PL396723A1
PL396723A1 PL396723A PL39672303A PL396723A1 PL 396723 A1 PL396723 A1 PL 396723A1 PL 396723 A PL396723 A PL 396723A PL 39672303 A PL39672303 A PL 39672303A PL 396723 A1 PL396723 A1 PL 396723A1
Authority
PL
Poland
Prior art keywords
application
receptor binding
neoplastic diseases
binding factors
edg receptor
Prior art date
Application number
PL396723A
Other languages
English (en)
Inventor
Thomas Baumruker
Volker Brinkmann
Montagne Kenneth Richard La
Peter T. Lassota
Diana Mechtcheriakova
Jeanette Marjorie Wood
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0211261A external-priority patent/GB0211261D0/en
Priority claimed from GB0217150A external-priority patent/GB0217150D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL396723A1 publication Critical patent/PL396723A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL396723A 2002-05-16 2003-05-15 Zastosowanie czynników wiążących receptory EDG w chorobach nowotworowych PL396723A1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0211261A GB0211261D0 (en) 2002-05-16 2002-05-16 Organic compounds
US39041102P 2002-06-20 2002-06-20
GB0217150A GB0217150D0 (en) 2002-07-24 2002-07-24 Organic compounds
US44973903P 2003-02-24 2003-02-24

Publications (1)

Publication Number Publication Date
PL396723A1 true PL396723A1 (pl) 2011-12-19

Family

ID=43508462

Family Applications (1)

Application Number Title Priority Date Filing Date
PL396723A PL396723A1 (pl) 2002-05-16 2003-05-15 Zastosowanie czynników wiążących receptory EDG w chorobach nowotworowych

Country Status (7)

Country Link
KR (5) KR20120025018A (pl)
DK (1) DK1944026T3 (pl)
ES (1) ES2428697T3 (pl)
PL (1) PL396723A1 (pl)
PT (1) PT1944026E (pl)
SI (1) SI1944026T1 (pl)
TW (2) TWI341197B (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法

Also Published As

Publication number Publication date
TW200906381A (en) 2009-02-16
KR20130088904A (ko) 2013-08-08
KR20110094154A (ko) 2011-08-19
DK1944026T3 (da) 2013-09-30
ES2428697T3 (es) 2013-11-08
TWI341197B (en) 2011-05-01
KR101299873B1 (ko) 2013-08-23
KR20120025018A (ko) 2012-03-14
TWI340036B (en) 2011-04-11
TW200307533A (en) 2003-12-16
SI1944026T1 (sl) 2013-10-30
KR20100133027A (ko) 2010-12-20
PT1944026E (pt) 2013-09-18
KR20050003460A (ko) 2005-01-10

Similar Documents

Publication Publication Date Title
EP1572131A4 (en) ANTIBODY THERAPY
GB0212885D0 (en) Therapeutic epitopes and uses thereof
PT2368907T (pt) Anticorpos anti-abeta e a sua utilização
ZA200604074B (en) Anti-IGFR1 antibody therapeutic combinations
EP1551447A4 (en) ANTI-ADDL ANTIBODIES AND USES THEREOF
GB2384281B (en) Flexible Slide Joint
AP2127A (en) Multi-carbide material manufacture and use
GB0210517D0 (en) Material
AU2003255544A8 (en) Tumor specific oligosaccharide epitopes and use thereof
IL166063A0 (en) Antibodies and uses thereof
IL166361A0 (en) Binding molecules
AU2003298582A8 (en) Therapeutic guanidines
PL396723A1 (pl) Zastosowanie czynników wiążących receptory EDG w chorobach nowotworowych
GB0226723D0 (en) Antibodies for in vitro use
GB0223272D0 (en) A protein involved in therapy
GB0224014D0 (en) A protein involved in therapy
GB0209096D0 (en) Material applicator
GB0224013D0 (en) A protein involved in therapy
AU2003270518A8 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
GB0208935D0 (en) Backing material
GB0229875D0 (en) Protein involved in cancer
AU2003285574A8 (en) Chimaeric molecules
GB0211067D0 (en) Material
GB0221487D0 (en) A protein involved in pancreatic cancer
PL355243A1 (pl) Dozownik kleju

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)